From: Metabolic syndrome and esophageal cancer risk: a systematic review and meta‑analysis
Omitted study | Heterogeneity | Model | Meta-analysis | |||
---|---|---|---|---|---|---|
I2 (%) | P | Pooled OR | 95% CI of pooled OR | P | ||
Drahos (2016) | 33 | 0.20 | Fixed-effect | 1.17 | 1.08–1.26 | < 0.0001 |
Drahos (2017) | 37 | 0.18 | Fixed-effect | 1.17 | 1.02–1.35 | 0.03 |
Duggan (2013) | 37 | 0.17 | Fixed-effect | 1.16 | 1.08–1.25 | < 0.0001 |
Ko (2016) | 0 | 0.88 | Fixed-effect | 1.17 | 1.09–1.26 | < 0.0001 |
Lin (2015) | 37 | 0.18 | Fixed-effect | 1.16 | 1.08–1.25 | < 0.0001 |
Lindkvist (2014) | 25 | 0.25 | Fixed-effect | 1.14 | 1.05–1.24 | 0.001 |